1. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012 Jun;64(6):1697-707. doi: 10.1002/art.34453.
2. Creamer P, Hochberg MC. Osteoarthritis. Lancet 1997 Aug 16;350(9076):503-8. doi: 10.1016/S0140- 6736(97)07226-7.
3. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA et al; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008 Jan;58(1):26-35. doi: 10.1002/art.23176.
4. Grässel S, Muschter D. Peripheral Nerve Fibers and Their Neurotransmitters in Osteoarthritis Pathology. Int J Mol Sci. 2017 Apr 28;18(5):931. doi: 10.3390/ijms18050931.
5. Jones KB, Mollano AV, Morcuende JA, Cooper RR, Saltzman CL. Bone and brain: a review of neural, hormonal, and musculoskeletal connections. Iowa Orthop J. 2004;24:123-32.
6. Qiao Y, Wang Y, Zhou Y, Jiang F, Huang T, Chen L, et al. The role of nervous system in adaptive response of bone to mechanical loading. J Cell Physiol. 2019 Jun;234(6):7771-7780. doi: 10.1002/jcp.27683.
7. Salo PT, Seeratten RA, Ewin WM, Bray RC. Evidence for a neuropathic contribution to the development of spontaneous knee osteoarthrosis in a mouse model. Acta Orthop Scand. 2002 Jan;73(1):77-84. doi: 10.1080/000164702317281459.
8. Grässel SG. The role of peripheral nerve fibers and their neurotransmitters in cartilage and bone physiology and pathophysiology. Arthritis Res Ther. 2014;16(6):485. doi: 10.1186/s13075-014-0485- 1.
9. Mashaghi A, Marmalidou A, Tehrani M, Grace PM, Pothoulakis C, Dana R. Neuropeptide substance P and the immune response. Cell Mol Life Sci. 2016 Nov;73(22):4249-4264. doi: 10.1007/s00018- 016-2293-z.
10. Suri S, Gill SE, Massena de Camin S, Wilson D, McWilliams DF, Walsh DA. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheuma Dis. 2007 Nov;66(11):1423-8. doi: 10.1136/ard.2006.063354.
11. Ogino S, Sasho T, Nakagawa K, Suzuki M, Yamaguchi S, Higashi M, et al. Detection of pain-related molecules in the subchondral bone of osteoarthritis knees. Clin Rheumatol. 2009 Dec;28(12):1395- 402. doi: 10.1007/s10067-009-1258-0.
12. Zieglgänsberger W. Substance P and pain chronicity. Cell Tissue Res. 2019 Jan;375(1):227-241. doi: 10.1007/s00441-018-2922-y.
13. Wang L, Zhao R, Shi X, Wei T, Halloran BP, Clark DJ, et al. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone. 2009 Aug;45(2):309-20. doi: 10.1016/j.bone.2009.04.203.
14. Muraoka T, Hagino H, Okano T, Enokida M, Teshima R. Role of subchondral bone in osteoarthritis development: a comparative study of two strains of guinea pigs with and without spontaneously occurring osteoarthritis. Arthritis Rheum. 2007 Oct;56(10):3366-74. doi: 10.1002/art.22921.
15. Radin EL, Rose RM. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop Relat Res. 1986 Dec;(213):34-40.
16. Botter SM, van Osch GJ, Waarsing JH, van der Linden JC, Verhaar JA, Pols HA, et al. Cartilage damage pattern in relation to subchondral plate thickness in a collagenase‐induced model of osteoarthritis. Osteoarthritis Cartilage. 2008 Apr;16(4):506-14. doi: 10.1016/j.joca.2007.08.005.
17. Kim SJ, Kim JE, Kim SH, Kim SJ, Jeon SJ, Kim SH, et al. Therapeutic effects of neuropeptide substance P coupled with seif-assembled peptide nanofibers on the progression of osteoarthritis in a rat model. Biomaterials. 2016 Jan;74:119-30. doi: 10.1016/j.biomaterials.2015.09.040.
18. Jiang MH, Chung E, Chi GF, Ahn W, Lim JE, Hong HS, et al. Substance P induces M2-type macropharges after spinal cord injury. Neuroreport. 2012 Sep 12;23(13):786-92. doi: 10.1097/WNR.0b013e3283572206.
19. Kim JE, Lee JH, Kim SH, Jung Y. Skin Regeneration with Self-Assembled Peptide Hydrogels Conjugated with Substance P in a Diabetic Rat Model. Tissue Eng Part A. 2018 Jan;24(1-2):21-33. doi: 10.1089/ten.TEA.2016.0517.
20. Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis and cartilage. 2007 Sep;15(9):1061-9. doi: 10.1016/j.joca.2007.03.006.
21. Kanemitsu M, Nakasa T, Shirakawa Y, Ishikawa M, Miyaki S, Adachi N. Role of vasoactive intestinal peptide in the progression of osteoarthritis through bone sclerosis and angiogenesis in subchondral bone. J Orthop Sci 2020 Sep;25(5):897-906. doi: 10.1016/j.jos.2019.11.010.
22. Utsumi D, Matsumoto K, Amagase K, Horie S, Kato S. 5-HT3 receptors promote colonic inflammation via activation of substance P/neurokinin-1 receptors in dextran sulphate sodiuminduced murine colitis. Br J Pharmacol. 2016 Jun;173(11):1835-49. doi: 10.1111/bph.13482.
23. Chang FY, Lee SD, Yeh GH, Wang PS. Rat gastrointestinal motor responses mediated via activation of neurokinin receptors. J Gastroenterol Hepatol. 1999 Jan;14(1):39-45. doi: 10.1046/j.1440- 1746.1999.01808.x.
24. Lacourt M, Gao C, Li A, Girard C, Beauchamp G, Henderson JE, Laverty S. Relationship between cartilage and subchondral bone lesions in repetitive impact trauma-induced equine osteoarthritis. Osteoarthritis and cartilage. 2012 Jun;20(6):572-83. doi: 10.1016/j.joca.2012.02.004.
25. Nagira K, Ikuta Y, Shinohara M, Sanada Y, Omoto T, Kanaya H, et al. Histological scoring system for subchondral bone changes in murine models of joint aging and osteoarthritis. Sci Rep 2020 Jun 22;10(1):10077. doi:10.1038/s41598-020-66979-7.
26. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2006 Jan;14(1):13-29. doi: 10.1016/j.joca.2005.07.014.
27. Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis and Cartilage. 2010 Oct;18 Suppl 3:S17-23. doi: 10.1016/j.joca.2010.05.025.
28. Lewis JS, Hembree WC, Fuman BD, Tippets L, Cattel D, Huebner JL, et al. Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse knee. Osteoarthr Cartil 2011 Jul;19(7):864-73
29. Zemmyo M, Meharra EJ, Kühn K, Creighton-Achermann L, Lotz M. Accelerated, aging-dependent development of osteoarthritis in alpha1 integrin-deficient mice. Arthritis Rheum. 2003 Oct;48(10):2873-80. doi: 10.1002/art.11246.
30. Takada T, Miyaki S, Ishitobi H, Hirai Y, Nakasa T, Igarashi K, et al. Bach1 deficiency reduces severity of osteoarthritis through upregulation of heme oxygenase-1. Arthritis Res Ther. 2015 Oct 13;17:285. doi: 10.1186/s13075-015-0792-1.
31. Stanton H, Golub SB, Rogerson FM, Last K, Little CB, Fosang AJ. Investigating ADAMTS-mediated aggrecanolysis in mouse cartilage. Nat Protoc. 2011 Mar;6(3):388-404. doi: 10.1038/nprot.2010.179.
32. Millward-Sadler SJ, Mackenzie A, Wright MO, Lee HS, Elliot K, Gerrard L, et al. Tachykinin expression in cartilage and function in human articular chondrocyte mechanotransduction. Arthritis Rheum. 2003 Jan;48(1):146-56. doi: 10.1002/art.10711.
33. Opolka A, Straub RH, Pasoldt A, Grifka J, Grässel S. Substance P and norepinephrine modulate murine chondrocyte proliferation and apoptosis. Arthritis Rheum. 2012 Mar;64(3):729-39. doi: 10.1002/art.33449.
34. Hong HS, Son Y. Substance P ameliorates collagen II-induced arthritis in mice via suppression of the inflammatory response. Biochem Biophys Res Commun. 2014 Oct 10;453(1):179-84. doi: 10.1016/j.bbrc.2014.09.090.
35. Hong HS, Lee J, Lee E, Kwon YS, Lee E, Ahn W, et al. A new role of substance P as an injuryinducible messenger for mobilization of CD29(+) stromal-like cells. Nat Med. 2009 Apr;15(4):425- 35. doi: 10.1038/nm.1909.
36. An YS, Lee E, Kang MH, Hong HS, Kim MR, Jang WS, et al. Substance P stimulates the recovery of bone marrow after the irradiation. J Cell Physiol. 2011 May;226(5):1204-13. doi: 10.1002/jcp.22447.
37. Kang MH, Kim DY, Yi JY, Son Y. Substance-P accelerates intestinal tissue regeneration after gamma irradiation-induced damage. Wound Repair Regen. Mar-Apr 2009;17(2):216-23. doi: 10.1111/j.1524-475X.2009.00456.x.
38. Delgado AV, McManus AT, Chambers JP. Exogenous administration of substance P enhances wound healing in a novel skin-injury model. Exp Biol Med. 2005 Apr;230(4):271-80.
39. Muschter D, Fleischhauer L, Taheri S, Schilling AF, Clausen-Schaumann H, Grässel S. Sensory neuropeptides are required for bone and cartilage homeostasis in a murine destabilization-induced osteoarthritis model. Bone 2020;133:115181
40. Nakasa T, Ishikawa M, Takada T, Miyaki S, Ochi M. Attenuation of cartilage degeneration by calcitonin gene-related peptide receptor antagonist via inhibition of subchondral bone sclerosis in osteoarthritis mice. J Orthop Res. 2016 Jul;34(7):1177-84. doi: 10.1002/jor.23132.
41. Hong S, Hwang DY, Park JH, Kim S, Seo EJ, Son Y. Substance-P alleviates dextran sulfate sodiuminduced intestinal damage by suppressing inflammation through enrichment of M2 macrophages and regulatory T cells. Cytokine. 2017;90:21-30. doi: 10.1016/j.cyto/2016.10.002.
42. Kim S, Piao J, Hwang DY, Park JS, Son Y, Hong HS. Substance P accelerates wound repair by promoting neovascularization and preventing inflammation in an ischemia mouse model. Life Sci 2019;225:98-106. doi.10.1016/j.lfs.2019.04.015.
43. Baek SM, Son Y, Hong HS. Substance P blocks the impairment of paracrine potential of MSC due to long term culture. Mol Cell Toxicol 2018;14:283-290. doi:10.1007/s13273-018-0031-3.
44. Zhang YB, Wang L, Jia S, Du ZJ, Zhao YH, Liu YP, et al. Local injection of substance P increases bony formation during mandibular distraction osteogenesis in rats. Br J Oral Maxillofac Surg. 2014 Oct;52(8):697-702. doi: 10.1016/j.bjoms.2014.07.002.
45. Suvas S. Role of substance P neuropeptide in inflammation, wound healing, and tissue homeostasis. J Immunol 2017 Sep 1;199(5):1543-1552